European Journal of Cardiovascular Medicine

Background: It has been proposed that, thrombocytopenia is the most common haematological abnormality in pregnancy after anaemia. The incidence of severe immune thrombocytopenia (ITP) in pregnancy has been difficult to report because of the rarity of the disease. Aims and objectives: Objectives were to determine the prevalence, pregnancy outcomes, treatment modalities of ITP mothers in a tertiary health care hospital in West Bengal, India. Methods: Our study was a retrospective record study. Records of the in-patient medical record department (MRD) folders of patients with ITP who delivered at Dept of G&O, N.R.S. Medical College and Hospital, Kolkata, West Bengal, India from November 2018 to November 2022. Statistical data were analysed by using SPSS V.20 software. Results: Most common age group of the mother found to 19-25 years 10 (43.5%). Gravida 1 was 11 (47.8%), followed by gravida 2 was 8 (34.83%). IUFD was 1 (4.3%), preterm was 7 (30.4%), SA was 2 (8.7%), term was 12 (52.2%) and neonatal death was 2 (8.7%). Associated Haematological Disorder of B Thal Trait and HbE Carrier was 3 (10.3%) each. Platelet Count during AN Period as <49000 was 13 (56.5%) and 50000-99,999 was 10 (43.5%). Myasthenia gravis during pregnancy was 7 (30.4%), Methylprednisolone was 3 (13.0%), thyroid disorder was among 5 (21.7%). Conclusion: Chronic ITP in pregnancy poses more risks to mother and foetus as seen with the higher chance of PPH etc. Mothers with ITP should be screened antenatally as the chances of anomalies are high in foetus.